13D/13G Filings - Vir Biotechnology Inc. (VIR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
1:57 pm
Purchase
2021-02-1613GVir Biotechnology, Inc.
VIR
Capital International Investors11,440,571
9.000%
11,440,571increase
(New Position)
Filing
History
2021-02-16
07:08 am
Sale
2020-12-3113GVir Biotechnology, Inc.
VIR
Alaska Permanent Fund Corp3,893,040
3.060%
-1,662,516decrease
(-29.93%)
Filing
History
2021-02-12
5:00 pm
Purchase
2020-12-3113GVir Biotechnology, Inc.
VIR
SCANGOS GEORGE A7,001,308
5.500%
52,329increase
(+0.75%)
Filing
History
2021-02-11
06:02 am
Purchase
2020-12-3113GVir Biotechnology, Inc.
VIR
Temasek Holdings (Private) Limited5,499,999
4.300%
5,499,999increase
(New Position)
Filing
History
2020-07-29
3:50 pm
Unchanged
2020-07-0813DVir Biotechnology, Inc.
VIR
ARCH Venture Fund IX, L.P.28,666,663
23.000%
0
(Unchanged)
Filing
History
Goto Prev, 0, 1